Yuge!: 'SNL' sees biggest premiere audience in 8 years thanks to Baldwin's Trump

Yuge!: 'SNL' sees biggest premiere audience in 8 years thanks to Baldwin's Trump

‘Saturday Night Live’ returns with Baldwin’s Trump facing off against McKinnon’s Clinton Alec Baldwin’s Donald Trump gave “Saturday Night Live” an election bump. Bigly. The premiere of this season of “SNL” brought in an average of 8.3 million viewers on Saturday night, according to Nielsen data. That was a bump of 31%, or nearly 2 → Read More

Dow Chemical Stock: How the Chemical Giant Bounced Back

Dow Chemical Stock: How the Chemical Giant Bounced Back

For more than a century, Dow Chemical (NYSE:DOW) has been a leader in the chemicals industry. As a provider of chemical, plastics, and agricultural products and services, Dow has a worldwide presence that includes both consumer products and goods aimed at industrial customers. Yet after such a long and illustrious history, Dow had to survive → Read More

Trump myths vs. reality on trade

Trump myths vs. reality on trade

How Donald Trump could have avoided taxes on $916 million Donald Trump paints global trade as a zero-sum game. They win, America loses. “We have to stop these countries from stealing our companies and our jobs,” Trump said at the debate last week. Read More

Why Celldex Therapeutics, Inc. Jumped Higher Today

Why Celldex Therapeutics, Inc. Jumped Higher Today

What happened Celldex Therapeutics (NASDAQ:CLDX) stock was up as much as 12.3% today, but has given a little back, trading up 8.4% at 12:57 p.m. EDT after Brean Capital started coverage on the biotech with a “buy” rating and a $16 price target. So what Last week, the European Society for Medical Oncology (ESMO) abstracts for → Read More

A Good Bank for Investors Isn't Necessarily Great for Consumers

A Good Bank for Investors Isn't Necessarily Great for Consumers

At The Motley Fool, we tend to talk about companies from the perspective of investors, not consumers. But while these two perspectives can sometimes meld, that’s rare in the bank industry, as we all learned recently when it was revealed that thousands of Wells Fargo (NYSE:WFC) employees opened up to 2 million fraudulent accounts for → Read More

Google makes fun of Apple's missing headphone jack

Google makes fun of Apple's missing headphone jack

See Google’s new messaging app, Allo Google unveiled a new phone on Tuesday — and took a couple digs at chief rival Apple. At a press event in San Francisco, Google (GOOGL, Tech30) announced the Pixel, a phone that is billed as the first ever made by Google “inside and out.” Google touted the device’s → Read More

Nike's self-lacing sneaker is available today … via lottery

Nike's self-lacing sneaker is available today … via lottery

Nike just brought ‘Back to the Future’ into reality Nike just unveiled a small batch of “Back to the Future” sneakers, and you can win them via an online lottery that starts Tuesday. There are only 89 pairs of the self-lacing Nike Mag sneaker available. Tickets cost $10, and there’s no limit to how many → Read More

Seadrill Ltd. Stock Up 29% on Debt Rumors: Here's What You Need to Know

Seadrill Ltd. Stock Up 29% on Debt Rumors: Here's What You Need to Know

What Shares of offshore drilling contractor Seadrill Ltd. (NYSE:SDRL) are up 28.8% at noon EDT on Oct. 4, following a report by Bloomberg that its chairman and largest shareholder, John Fredriksen, was preparing to lend the company as much as $1.2 billion.  So what This is potentially a huge positive for Seadrill, which faces $2.4 billion in → Read More

3 Reasons Ambarella Inc. Stock Could Fall

3 Reasons Ambarella Inc. Stock Could Fall

Though Ambarella (NASDAQ:AMBA) stock has climbed more than 30% year to date as of this writing, longtime shareholders of the video processing chip specialist know it hasn’t been a smooth ride.  Ambarella stock kicked off 2016 with a precipitous decline, promptly falling 40% from the beginning of the year before hitting a fresh 52-week low → Read More

Why I'm Bullish on 3M But Not Chemours

Why I'm Bullish on 3M But Not Chemours

It’s not easy being a chemical company these days, especially not a chemical company with a long history. And both 3M (NYSE:MMM) and Chemours (NYSE:CC) fall into that category. There’s one particular chemical that’s causing looming legal headaches for both companies right now — however, 3M is better equipped to weather the storm than Chemours. Here’s why. A long → Read More

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.